Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Torres Arevalo, Janina Tatiana"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Factores clínicos gastrointestinales como expresión fenotípica de COVID-19. Revisión bibliográfica
    (2022) Torres Arevalo, Janina Tatiana
    Introduction: the appearance of the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or Coronavirus Disease 2019 (COVID-19) and its rapid spread, caused a worldwide health emergency. This virus mainly affects the respiratory system, but also the gastrointestinal tract.Objective: to identify if the secondary gastrointestinal manifestations to COVID-19 infection are an important phenotypic expression of this pathology.Methodology: a systematic search was carried out in scientific medical journals in the databases: Scielo, PubMed, SpringerLink, Wiley Online Library, Scopus with the following terms “Gastrointestinal manifestations due to COVID-19”, “Gastrointestinal symptoms due to SARS-CoV2”, “Gastrointestinal alterations in COVID-19”, published in English and Spanish between 2020 and 2021.Results: the most frequent gastrointestinal symptoms were diarrhea, nausea, vomiting, anorexia and abdominal pain. The physiopathology of gastrointestinal manifestations depends on angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). The detection of viral RNA in feces as a diagnosis has been detected in 53.4% of infected patients, other methods described are not definitive. Finally, the treatment of gastrointestinal manifestations due to COVID-19 is symptomatic.Conclusions: the advances in the epidemiology, pathogenesis, clinical characteristics, means of diagnosis and treatment of COVID-19, show that secondary gastrointestinal manifestations occur in a manner and frequency variable, allowing to face this epidemic disease more effectively.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback